This website uses cookies to ensure you get the best experience on our website. Privacy Policy

Contact
Login
Sign Up Free

Transformative Evidence
- mCRPC
- mHSPC
  - ARANOTE Trial
  - ARASENS Trial
- nmCRPC
  - ARAMIS Trial
- nmCSPC
  - EMBARK Trial
- PSMA PET Imaging
- Bladder Cancer
Centers of Excellence
- Urologic Oncology
  - Left Group
    - Health Policy
      - Health Policy
        Ruchika Talwar, MD
    - Bladder Cancer
    - Kidney Cancer
      - Advanced Kidney Cancer
        Pedro Barata, MD, MSc
    - Endourology
      - Endourology
        Jaime Landman, MD
  - Prostate Cancer
  - Disparities: Social Determinants of Health
    - Disparities: Social Determinants of Health
      Samuel L. Washington III, MD, MAS
  - Translational Prostate Cancer
    - Translational Science in Prostate Cancer
      Andrea Miyahira, Ph.D
    - Women in Science
      Andrea Miyahira, Ph.D
  - Upper Tract Urothelial Carcinoma
    - Upper Tract Urothelial Carcinoma
      Sam S. Chang, MD, MBA
  - TESTICULAR, PENILE & RARE GU MALIGNANCIES
    - Testicular Cancer
- Pelvic Health & Reconstruction
Videos
- Exclusives
- Urologic Oncology
- Pelvic Health & Reconstruction
  - Pelvic Health & Reconstruction
Trials in Progress
- Trials in Progress
  - Bladder Cancer
    - IMMORTAL
    - PIVOT-006
  - Kidney Cancer
    - RadiCal
    - SAMURAI
- Middle Side
  - Prostate Cancer
- Right Side
  - Prostate Cancer
Clinical Trials
- From the Editor
  - Search Clinical Trials
Articles
- Urology (benign and malignant)
- Pelvic Health
  - Pelvic Health & Reconstruction
Conference Coverage
- Recent Conferences
- All Conferences
  - View All
- Quick Takes
  - ESMO 2024
PCF

UroToday Home
Newsletter Archive

ESMO 2024

Practice-Changing Prostate Cancer Clinical Trials Data - ARANOTE - PREACE-3 and SPLASH Sent on 22 October 2024 Receive via e-mail

How to Personalize Therapy in mHSPCSent on 23 September 2024 Receive via e-mail

ESMO 2024: Informing Clinical Practice in Bladder Cancer and Renal CancerSent on 20 September 2024 Receive via e-mail

SPLASH Trial Highlights Radiopharmaceutical Lutetium-177’s Role in Advanced Prostate Cancer Treatment and More on Prostate CancerSent on 19 September 2024 Receive via e-mail

ESMO 2024 Practice Changing Prostate Cancer Trial Results Sent on 17 September 2024 Receive via e-mail

ESMO 2024 Informing GU Cancer TreatmentsSent on 16 September 2024 Receive via e-mail

ESMO 2024 Presidential Symposium II NIAGRA A Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder CancerSent on 16 September 2024 Receive via e-mail

ESMO 2024: SPLASH 177Lu-PNT2002 Improves Radiographic Progression-Free Survival in mCRPC Patients Sent on 15 September 2024 Receive via e-mail

ESMO 2024 Practice Changing Trials - First Results PEACE 3Sent on 14 September 2024 Receive via e-mail

ESMO 2024 Novel Therapeutic Approaches for ARPI-Resistant Disease and Bladder Preservation StrategiesSent on 14 September 2024 Receive via e-mail

European Society of Medical Oncology (ESMO) 2024 - Toni Choueiri Discusses TiNivo-2 Trial Results and More on GU CancersSent on 13 September 2024 Receive via e-mail

European Society for Medical Oncology (ESMO) 2024 Annual Congress Coverage Starts FridaySent on 10 September 2024 Receive via e-mail

Display #
Results 1 - 12 out of 12

Send the selected Newsletters to...

Name
E-mail

About UroToday
Journals
Calendar
Editorial and Advertising Guidelines
Editors and Contributors
FAQs
Privacy Policy
Terms of Use

Follow UroToday

COPYRIGHT © 2002 - 2024 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

Email

Password

Forgot Password?
Sign Up Free